El ejemplo de superación de los sobrevivientes de la Tragedia de los Andes, hace 50 años, "me hizo pensar en los desafíos y etapas que deben superar mis pacientes desde que se enteran de que tienen cáncer", señaló el oncólogo Fernando Petracci MD, MSc. espanol.medscape.com/verarticulo/59…

#QoL #breastcancer by Mariana Chávez MacGregor #LOF Pfizer Inc. Fernando Petracci MD, MSc

"De Vuelta A La Vida", sin más palabras. Solo tenes que verlo. devueltaalavida.com/ver-documental @starbucksargentina @vdll_cancerdemama2022 instagram.com/p/Cj60D8lLPRH/…

instagram.com/stories/fernan…

Acaba de publicar una foto en Aeropuerto Internacional El Dorado instagram.com/p/Ckg-ix7rluI/…

So proud to be part of this international meeting in Buenos Aires ! Let's work

Acaba de publicar una foto instagram.com/p/CklPCVkLQdQ/…

The hardest #top10 (ish) I’ve ever done for a meeting: the amount of critical data that will be presented at #SABCS22 is impressive. Novel drugs, important trial updates, highly awaited biomarker data, new paradigms. Make sure not to miss what promises to be a remarkable SABCS!

5:45 let's flight. Destino Bariloche. Congreso Patagonia Cáncer de Mama. Amigos, colegas, discusiones y cordillera 🙌#breastcancercure en Buenos Aires, Argentina instagram.com/p/ClGKIVjOyRM/…

Acaba de publicar una foto instagram.com/p/ClTZ4ZcLSF1/…

Proud to have been part of this project. Real-World Evidence Opportunities to Enhance Local Decision-Making in Oncology for Emerging Markets: A Multi-Regional Oncologist & Payer Committee Perspective. #ISPORAnnual 2023 Poster ispor.org/docs/default-s… #rwe

Happy to meet many colleagues from latin america at #ASCO2023 . Working together to create the Latin-American Breast Cancer Association #LABCA . Ambitious project but necessary for the region.

#ASCO2023 #Cobertura #ScienceLink Dr. Juan Carlos Samamé (Juan Carlos SamaméPV) y Dr. Fernando Petracci (Fernando Petracci MD, MSc) shorturl.at/ipsOX

Just out on ESMO Open a global, retrospective study by Viale et al. on HER2-low (vs 0) breast cancer (n=789). No notable differences in features & outcomes were found between HER2-low vs HER2-0 cases. Upon rescoring, >30% of HER2-0 cases became HER2-low. esmoopen.com/article/S2059-…

The phase 3 trial of the novel anti-HER2 ADC DB-1303 in HER2-low breast cancer will be called “DYNASTY-Breast02”. 🤯

infobae.com/salud/2023/12/…

Invitamos a todos a realizar la preinscripción para asociarse a LABCA (Latin American Breast Cancer Association) +Info: labca.ong/preinscripcion… #labca #BreastCancer #cancerdemama #latam #cancer #oncologia #socios #asociate

🎗️ Webinar: Cáncer de Mama #HER2Positivo Invitamos a Oncólogos y profesionales de la salud a un evento virtual de alto nivel sobre #CáncerDeMama HER2+ y la modificación del riesgo basado en tratamiento 🔗 labca.ong/webinar-cancer… #Oncología #WebinarMédico #LABCA #SVM #Salud